Robert Win Maw Min

529 total citations
7 papers, 423 citations indexed

About

Robert Win Maw Min is a scholar working on Pharmacology, Molecular Biology and Epidemiology. According to data from OpenAlex, Robert Win Maw Min has authored 7 papers receiving a total of 423 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pharmacology, 3 papers in Molecular Biology and 3 papers in Epidemiology. Recurrent topics in Robert Win Maw Min's work include Drug-Induced Hepatotoxicity and Protection (4 papers), Liver Disease Diagnosis and Treatment (3 papers) and Melanoma and MAPK Pathways (3 papers). Robert Win Maw Min is often cited by papers focused on Drug-Induced Hepatotoxicity and Protection (4 papers), Liver Disease Diagnosis and Treatment (3 papers) and Melanoma and MAPK Pathways (3 papers). Robert Win Maw Min collaborates with scholars based in United States and China. Robert Win Maw Min's co-authors include Sanda Win, Tin Aung Than, Neil Kaplowitz, Mariam Aghajan, Jun Zhang, Sheng Zhou, Jun Zhang, Ayako Suzuki, Yibu Chen and Meng Li and has published in prestigious journals such as Journal of Clinical Investigation, SHILAP Revista de lepidopterología and Hepatology.

In The Last Decade

Robert Win Maw Min

7 papers receiving 419 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert Win Maw Min United States 6 182 179 147 129 51 7 423
A Mahli Germany 12 158 0.9× 126 0.7× 193 1.3× 60 0.5× 72 1.4× 21 472
Heather S. Johnson United States 5 149 0.8× 130 0.7× 140 1.0× 68 0.5× 34 0.7× 8 342
Guangdong Tong China 14 164 0.9× 85 0.5× 219 1.5× 85 0.7× 25 0.5× 48 463
Xiaoyan Qiang China 6 188 1.0× 93 0.5× 194 1.3× 78 0.6× 140 2.7× 9 480
Simon Bucher France 13 144 0.8× 98 0.5× 138 0.9× 59 0.5× 63 1.2× 19 407
Tingying Jiao China 11 131 0.7× 75 0.4× 230 1.6× 59 0.5× 110 2.2× 15 467
David S. Umbaugh United States 12 146 0.8× 327 1.8× 144 1.0× 204 1.6× 81 1.6× 34 564
Shicheng Fan China 14 101 0.6× 121 0.7× 347 2.4× 97 0.8× 96 1.9× 44 619
Lieming Xu China 15 319 1.8× 128 0.7× 230 1.6× 269 2.1× 47 0.9× 24 651
Nancy W. Bethea United States 13 174 1.0× 243 1.4× 151 1.0× 305 2.4× 98 1.9× 14 684

Countries citing papers authored by Robert Win Maw Min

Since Specialization
Citations

This map shows the geographic impact of Robert Win Maw Min's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Win Maw Min with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Win Maw Min more than expected).

Fields of papers citing papers by Robert Win Maw Min

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Win Maw Min. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Win Maw Min. The network helps show where Robert Win Maw Min may publish in the future.

Co-authorship network of co-authors of Robert Win Maw Min

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Win Maw Min. A scholar is included among the top collaborators of Robert Win Maw Min based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Win Maw Min. Robert Win Maw Min is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Min, Robert Win Maw, et al.. (2022). Mechanism and Therapeutic Targets of c-Jun-N-Terminal Kinases Activation in Nonalcoholic Fatty Liver Disease. Biomedicines. 10(8). 2035–2035. 15 indexed citations
2.
Gangu, Karthik, Harleen Chela, Ömer Başar, et al.. (2021). Cutting out Cholecystectomy on Index Hospitalization Leads to Increased Readmission Rates, Morbidity, Mortality and Cost. SHILAP Revista de lepidopterología. 9(4). 89–89. 4 indexed citations
3.
Win, Sanda, Robert Win Maw Min, Jun Zhang, et al.. (2021). Hepatic Mitochondrial SAB Deletion or Knockdown Alleviates Diet‐Induced Metabolic Syndrome, Steatohepatitis, and Hepatic Fibrosis. Hepatology. 74(6). 3127–3145. 31 indexed citations
4.
Win, Sanda, Robert Win Maw Min, Jun Zhang, et al.. (2019). Expression of mitochondrial membrane–linked SAB determines severity of sex-dependent acute liver injury. Journal of Clinical Investigation. 129(12). 5278–5293. 35 indexed citations
5.
Zhang, Jun, Robert Win Maw Min, Sheng Zhou, et al.. (2017). The role of MAP2 kinases and p38 kinase in acute murine liver injury models. Cell Death and Disease. 8(6). e2903–e2903. 51 indexed citations
6.
Win, Sanda, et al.. (2017). New insights into the role and mechanism of c‐Jun‐N‐terminal kinase signaling in the pathobiology of liver diseases. Hepatology. 67(5). 2013–2024. 140 indexed citations
7.
Win, Sanda, Tin Aung Than, Robert Win Maw Min, Mariam Aghajan, & Neil Kaplowitz. (2016). c‐Jun N‐terminal kinase mediates mouse liver injury through a novel Sab (SH3BP5)‐dependent pathway leading to inactivation of intramitochondrial Src. Hepatology. 63(6). 1987–2003. 147 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026